University Of Southampton
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- -
- Established
- 1862-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://southampton.ac.uk/
Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer
Phase 3
- Conditions
- Colorectal CancerMetastatic Cancer
- Interventions
- Biological: cetuximabOther: study of socioeconomic and demographic variablesProcedure: adjuvant therapyProcedure: neoadjuvant therapyProcedure: quality-of-life assessment
- First Posted Date
- 2007-06-05
- Last Posted Date
- 2013-01-23
- Lead Sponsor
- University of Southampton
- Target Recruit Count
- 340
- Registration Number
- NCT00482222
- Locations
- π¬π§
Basildon University Hospital, Basildon, England, United Kingdom
π¬π§Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke, England, United Kingdom
π¬π§Royal Bournemouth Hospital, Bournemouth, England, United Kingdom
The Clinical Effectiveness of Static Resting Splints in Early Rheumatoid Arthritis
Not Applicable
Completed
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2007-05-17
- Last Posted Date
- 2007-05-17
- Lead Sponsor
- University of Southampton
- Target Recruit Count
- 120
- Registration Number
- NCT00474877
- Locations
- π¬π§
University of Southampton, Southampton, Hants, United Kingdom
Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Phase 2
Terminated
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2007-05-07
- Last Posted Date
- 2021-02-01
- Lead Sponsor
- University of Southampton
- Target Recruit Count
- 5
- Registration Number
- NCT00470249
- Locations
- π¬π§
Royal Bournemouth Hospital, Bournemouth, England, United Kingdom
π¬π§Portsmouth Oncology Centre at Saint Mary's Hospital, Portsmouth, England, United Kingdom
π¬π§Southampton General Hospital, Southampton, England, United Kingdom
Trial Evaluating Devil's Claw for the Treatment of Hip and Knee Osteoarthritis
Phase 2
Terminated
- Conditions
- Osteoarthritis, KneeOsteoarthritis, Hip
- Interventions
- Drug: Devil ClawDrug: Placebo
- First Posted Date
- 2006-02-23
- Last Posted Date
- 2011-09-12
- Lead Sponsor
- University of Southampton
- Target Recruit Count
- 67
- Registration Number
- NCT00295490
- Locations
- π¬π§
Wellcome Trust Clinical Research Facility, Southampton General Hospital, Southampton, Hants, United Kingdom